Upstream Manufacturing Webinars

  1. DynaDrive S.U.B. Video Series 4/1/2026

    Explore DynaDrive Single-Use Bioreactors through expert videos covering reactor design, mixing performance, sparge technology, and scalable workflows from bench-scale to commercial production.

  2. DynaDrive Single-Use Bioreactors Drilled-Hole Sparge Technology 3/30/2026

    Uniform bubble size and consistent mass transfer across scales through drilled-hole sparge technology improves oxygen delivery and CO2 stripping in demanding cell culture processes.

  3. DynaDrive Single-Use Bioreactors - One Reactor, Many Volumes 3/30/2026

    Single-use bioreactors with turndown ratios up to 20:1 enable facilities to operate across wide volume ranges within the same vessel, streamlining seed trains and reducing capital requirements for multi-product operations.

  4. Scale With Confidence From Bench To Commercial Production 3/30/2026

    Consistent vessel design, sparging, and bag materials across 1L to 5,000L volumes enable predictable bioreactor scale-up from development through commercial manufacturing.

  5. Why Is The Bioreactor Square? The Geometry Behind Exceptional Mixing 3/30/2026

    Cuboid bioreactor design eliminates vortexing through natural baffling, delivering homogeneous mixing and consistent nutrient distribution for high cell density upstream processes.

  6. Aegis Film For DynaDrive Single-Use Bioreactors 3/30/2026

    PFAS-free bioreactor film technology provides proven biocompatibility and strength across workflows while simplifying validation and reducing material variability for compliant operations.

  7. WuXia293Stable: Express What CHO Can't 3/26/2026

    Discover a modern 293‑based expression system built for higher purity, controlled glycosylation, and improved activity, offering a new option for teams developing complex or next‑generation biologics.

  8. Five Reasons To Choose Thermo Scientific DynaDrive Single-Use Bioreactors 3/25/2026

    Explore five key advantages of single-use bioreactors, including scalable design, homogeneous mixing, broad chemical compatibility, and streamlined seed train processes for bioproduction success.

  9. A Highly Productive, Chemically Defined Exosome Media System 3/24/2026

    Explore how chemically defined media and optimized bioreactor protocols increase exosome yields 40-fold while reducing commercial manufacturing costs from $10,000 to under $1,000 per dose.

  10. Flexible Therapeutic Development: Balancing Speed, Cost, and Process 3/24/2026

    Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.